Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Red Light Holland Corp. is a Canada-based life sciences and wellness company operating primarily in the psychedelics and functional mushroom industries, with a strategic focus on legally compliant markets. The company’s core business centers on the cultivation, distribution, and branding of psilocybin-containing truffles in jurisdictions where they are legal, alongside non-psychoactive functional mushroom products. Red Light Holland targets both recreational wellness consumers and emerging medical and research markets within regulated frameworks.
Founded in 2020, the company evolved rapidly through acquisitions and vertical integration, positioning itself as one of the few publicly traded companies with active legal psilocybin operations in Europe. Its strategy emphasizes near-term revenue generation in permissive markets while building optionality for future medical and therapeutic applications as regulations evolve. Red Light Holland differentiates itself through ownership of cultivation assets, wholesale distribution capabilities, and a focus on consumer-friendly branding rather than purely pharmaceutical drug development.
Business Operations
Red Light Holland generates revenue through several operating segments, including Legal Psilocybin Truffles, Functional Mushrooms, and Wholesale Distribution. Its psilocybin operations are primarily conducted through SR Wholesale, a Netherlands-based distributor supplying legal truffle products to smart shops, and iMicrodose branded consumer packs. Functional mushroom revenue is supported by cultivation and product sales in North America, leveraging owned agricultural infrastructure.
The company controls key assets across cultivation, processing, and distribution. Major subsidiaries include SR Wholesale, Mera Life Sciences Ltd., and Carleton Mushrooms. Mera Life Sciences Ltd., based in the Caribbean, supports research, cultivation, and export of psilocybin and functional mushrooms for scientific and regulated medical purposes. Operations span both domestic Canadian activities and international markets, with revenue primarily generated outside Canada due to domestic regulatory constraints.
Strategic Position & Investments
Red Light Holland’s strategic direction focuses on cash-generating legal markets while selectively investing in research-driven platforms that may benefit from future regulatory liberalization. Growth initiatives include expanding truffle distribution in Europe, increasing functional mushroom production capacity in North America, and developing intellectual property related to cultivation techniques and standardized dosing.
The company has completed several acquisitions to support vertical integration, including SR Wholesale and Carleton Mushrooms, and has invested in Mera Life Sciences Ltd. as a long-term platform for medical and scientific engagement. Red Light Holland is involved in emerging sectors such as psychedelic research supply, functional wellness products, and controlled-environment agriculture, while maintaining flexibility to pivot toward pharmaceutical or clinical pathways if regulations and capital conditions permit.
Geographic Footprint
Red Light Holland operates across North America, Europe, and the Caribbean, with corporate headquarters in Canada. Its most commercially active market is the Netherlands, where psilocybin truffles are legally sold through established retail channels. This European presence provides the company with current operating revenue uncommon among publicly traded psychedelic-focused peers.
In Canada, the company maintains cultivation, processing, and corporate operations, while St. Vincent and the Grenadines serves as a hub for research-oriented and export-focused activities through Mera Life Sciences Ltd. Collectively, these regions give Red Light Holland international exposure and regulatory diversification, reducing reliance on any single jurisdiction.
Leadership & Governance
Red Light Holland is led by an executive team with experience in capital markets, consumer branding, and emerging regulated industries. The leadership emphasizes pragmatic commercialization, regulatory compliance, and early revenue generation over speculative long-term drug development.
- Todd Shapiro – Chief Executive Officer
- Bruce Linton – Chair of the Board
- Sharyn Alexander – Chief Financial Officer
The company is governed by a board that includes executives with prior experience in cannabis, consumer packaged goods, and public company leadership, reflecting a strategic vision centered on disciplined growth and regulatory adaptability.